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Background: Although childhood cancer causes significant stress, most survivors are resilient 
and do not exhibit severe or lasting psychopathology. Research is limited, but some survivors 
may even report benefit finding or positive outcomes following this stressful life event. 
However, considerably less research has included families of children who are unlikely to 
survive their illness. Thus, this study investigated benefit finding among parents and their 
children with advanced cancer, as well as associated demographic and medical factors.  
Methods: Families (n = 57) of children with advanced cancer (ages 5-25) were recruited from a 
large pediatric hospital. Advanced cancer was defined as relapsed or refractory disease, a 
prognosis of <60%, or referral to end of life care. Participants completed a demographic survey 
and the Benefit Finding Scale at enrollment.  
Results: Children, mothers, and fathers reported moderate to high benefit finding scores. 
Correlations between family members were weak and non-significant. Children reported 
significantly higher benefit finding than fathers. Demographic and medical factors were not 
associated with benefit finding in children, mothers, or fathers.  
Conclusions: Families of children with advanced cancer reported moderate to high benefit 
finding regardless of background or medical factors. Children also identified benefits of their 
cancer experience independent of the experiences of their mothers and fathers. Larger studies 
should continue to examine factors associated with both positive and negative outcomes in the 
context of childhood cancer to inform more effective interventions.  
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Childhood cancer is the number one cause of death by disease for children ages 1-19 in 
the United States (Siegel et al., 2019). Over 20,000 children are newly diagnosed and about 
1,800 die from cancer each year. As treatment has improved, survival rates have also increased, 
with 83.4% of children now surviving cancer for at least 5 years (Siegel et al., 2019). The most 
common types of cancers in children under age 19 include leukemias (28%) and brain and 
nervous system cancers (26%). The most common diagnoses in adolescents ages 15-19 include 
brain and nervous system cancers (21%) and lymphomas (20%; Siegel et al., 2019). Treatment 
for each type of cancer varies, but most children receive multi-modal therapies, such as surgery, 
chemotherapy, radiation, and/or stem cell transplant. Depending on the diagnosis, treatment 
typically lasts from several months to three years and causes significant acute and chronic side 
effects, such as nausea, vomiting, hair loss, and fatigue. 
Cancer is a complex disease, causing significant stress in the lives of both the patient and 
their family as they cope with its challenges (Tedschi & Calhoun, 2004). Common stressors 
include changes in daily/role functioning, caregiving demands, and communicating about cancer. 
Mothers and fathers of children with cancer report caregiving as their most frequent stressor, 
partly due to the uncontrollability of helping their child feel better and uncertainty about their 
child’s survival (Rodriguez et al., 2011). Children with cancer face difficult treatments, painful 
procedures, and disruptions in their school and social activities. The most frequently reported 
stressor among children is not being able to do the things they were able to do before having 
cancer (Rodriguez et al., 2011). Some families exhibit ongoing challenges following a diagnosis, 
such as feeling disconnected from each other, being less involved in family activities, or failing 
to adjust family roles in times of stress (Long & Marsland, 2011).  
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Recent systematic reviews and meta-analyses indicate that parents are at risk for 
psychological distress in response to their child’s cancer diagnosis (Clark et al., 2009; Klassen et 
al., 2007; Pai et al., 2007; Vrijmoet-Wiersma et al., 2008). Symptoms of anxiety and depression 
are reportedly highest after diagnosis but tend to decrease over time (Vrijmoet-Wiersma et al., 
2008; Clark et al., 2009; Klassen et al., 2007; Pai et al., 2007). Among parents of children 
currently receiving cancer treatment, mothers generally report more distress and more stressors 
than fathers (Vrijmoet-Wiersma et al., 2008; Clark et al., 2009; Pai et al., 2007; Rodriguez et al., 
2011). However, some studies have found that fathers have higher levels of distress than 
mothers, particularly if they are the primary caregiver (Rosenberg et al., 2012; Long & Marsland, 
2011). When compared to parents without a child with cancer, levels of anxiety and depression 
in parents of children with cancer are higher (Vrijmoet-Wiersma et al., 2008). Some parents who 
report symptoms of anxiety or depression are at an increased risk for post-traumatic stress 
symptoms (PTSS) and/or maintaining depressive symptoms over time (Vrijmoet-Wiersma et al., 
2008; Clark et al., 2009; Klassen et al., 2007; Pai et al., 2007). When treatment is unsuccessful, 
parents of children at the end of life and bereaved parents have higher rates of PTSS and poorer 
adjustment when compared to parents of survivors (Rosenberg et al., 2012).  
Similar to parents, children diagnosed with cancer may experience psychological distress 
in response to their cancer experience. Many studies have found that children with cancer, or 
adult survivors of pediatric cancer, have worse quality of life and higher levels of distress (e.g., 
PTSS, anxiety, and depression) than healthy peers (Zeltzer et al., 2009, Compas et al., 2014, 
Portteus et al., 2006), while other studies have found no significant differences (Pinquart & Shen, 
2011, Bennett, 1994, Kersun, 2009). Children with leukemia or cancer of the central nervous 
system (CNS) are at higher risk for psychosocial difficulties (Krull et al., 2008; Wulff-Burchfield 
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et al., 2019; Zeltzer et al., 2009). Generally, these children receive more neurotoxic treatments 
that increase their risk for cognitive impairments, such as decreased attention, poor memory, and 
declines in global intelligence, which can then have downstream effects on social and emotional 
functioning (Zeltzer et al., 2009; Krull et al., 2008; Wulff-Burchfield et al., 2019).  
Although a subset of both parents and children with cancer struggle to cope with their 
diagnosis, most individuals are resilient and do not exhibit severe or lasting psychological 
distress (Stuber & Strom, 2012). Increasingly, positive psychology approaches have shifted away 
from focusing on psychological impairment, as has historically been done, instead aiming to 
understand competencies and adaptive functioning (Gable & Haidt, 2005). Benefit finding, the 
idea that someone can find positive outcomes from a stressful life event, is one such construct 
that has received more recent attention (Helgeson et al., 2006). Examples of benefit finding 
include a person with cancer realizing that they make more time for their relationships, or 
noticing the small things in life more often than before the stressful event.  
Benefit finding has been conceptualized in various ways. Posttraumatic growth and 
benefit finding are often considered the same construct, because they both describe a positive 
change or experience following a negative life event (Phipps et al., 2007). Despite their 
similarities, there are important theoretical distinctions between the two (Phipps et al., 2007). 
Benefit finding does not require an experience to be traumatic, whereas posttraumatic growth 
does. Benefit finding can occur regardless of whether the individual identifies a fundamental 
shift in their perspective on life. It can also occur in the midst a stressful life event, whereas 
posttraumatic growth takes time to develop after the conclusion of the trauma (Phipps et al., 
2007, Gardner et al., 2017). Some research has examined associations between child benefit 
finding and parent posttraumatic growth, finding that the two are positively related, but to our 
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knowledge, research has yet to examine associations between child and parent benefit finding 
(Michel et al., 2009). Given the limited research on benefit finding in pediatric cancer and recent 
evidence suggesting more overlap between the two constructs, literature about both 
posttraumatic growth and benefit finding are included (Applebaum et al., 2020). 
Demographic factors have been associated with benefit finding and posttraumatic growth 
among both adults and children with cancer. Younger adults tend to exhibit more posttraumatic 
growth and benefit finding from a cancer diagnosis than older adults, and the same was found in 
a longitudinal study of adolescent and young adults who were undergoing cancer treatment 
(Helgeson et al., 2006; Husson et el., 2017). However, research with children and adolescents 
found that older survivors reported more benefit and growth, suggesting a curvilinear association 
with age. Children first diagnosed with cancer above the age of 5 years old reported more 
posttraumatic growth than children younger than 5 years old. This could be explained by older 
survivors’ ablility to remember and understand their cancer experience, and then further reflect 
and incorporate that information into their beliefs about their life (Barakat et al., 2005). 
However, it is important to note that some studies have not found associations between age and 
benefit finding (Phipps et al., 2007).  
Biological sex has also been investigated in relation to benefit finding with mixed results. 
Among adults, women generally and women with cancer report more benefit finding and 
posttraumatic growth than men (Helgeson et al., 2006; Barakat et al., 2005; Tomich & Helgeson, 
2004; Husson et al., 2017). This may be explained by the tendency for women to be more 
emotion-focused when processing traumatic experiences and thus able to identify positive 
outcomes (Stanton et al., 2006). The data are mixed on sex differences in benefit finding among 
children with cancer. Some studies have found similar levels of benefit finding in females 
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compared to males (Phipps et al., 2007; Michel et al., 2010), while a study of 15-39 year old 
survivors of childhood cancer found that women reported more posttraumatic growth than men 
(Husson et al., 2017).  
Other demographic factors, like race and income, have been examined less frequently in 
relation to benefit finding. In the adult cancer literature, BIPOC (Black, Indigenous, people of 
color) individuals have shown higher levels of benefit finding when compared to white 
individuals (Helgeson et al., 2006). Other studies have found no differences in levels of 
posttraumatic growth based on race (Cordova et al., 2001, Husson et al., 2017). Children with 
cancer have replicated trends of BIPOC individuals showing more benefit finding than white 
individuals (Phipps et al., 2007). Associations between income and benefit finding have also 
been mixed, with some research finding no correlation between income and benefit finding, and 
others showing that as income decreases, benefit finding increases (Barakat et al., 2006, Cordova 
et al., 2001, Lechner et al., 2003).  
Time since diagnosis was found to positively correlate with benefit finding in a study 
with adult breast cancer survivors (Cordova et al., 2001), but other studies have found no 
association between time since diagnosis and posttraumatic growth (Stanton et al., 2006; 
Pakenham & Cox, 2009). These differences in findings may be explained by the fact that 
posttraumatic growth often takes time to develop and includes various stages an individual 
progresses through, such as rumination and cognitive restructuring, before growth from an 
adverse life event. Thus, it is necessary to consider how the timeframe of each study may affect 
the strength of correlations between time since diagnosis and benefit finding (Tedeschi et al., 
1998). For example, Stanton and colleagues found that posttraumatic growth was reported most 
frequently at one to two years after a cancer diagnosis (Stanton et al., 2006).  
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Other medical factors, such as diagnosis, are equally important to consider, as children 
with CNS tumors and leukemia are more likely to experience negative effects on cognitive 
functioning (Compas et al., 2017). Surgery, radiation, and chemotherapy, when directed to the 
CNS, can damage tissue and can result in cognitive and psychosocial difficulties in survivors 
(Marusaki et al., 2017). One study found that survivors of leukemia and CNS cancers 
experienced more benefit finding when compared to other solid tumors, however children with 
CNS cancer had lower rates of enrollment and study completion (Michel et al., 2010). The 
authors proposed that individuals that chose not to participate or did not complete the study may 
have declined due to cognitive difficulties from their treatment (Michel et al., 2010). Thus far, 
there is little literature investigating the association between diagnosis type and benefit finding.  
Positive psychology remains a fairly new field (Helgeson et al., 2006), and to date, 
benefit finding, posttraumatic growth, and resilience, are often considered equivocal, rather than 
recognizing a distinction between these constructs. Most research has examined benefit finding 
in adults with cancer, while few studies have included children with cancer. Of these studies, 
most occur during survivorship or have a heterogenous sample, including both children who 
were newly diagnosed with cancer and children who are many years past their diagnosis 
(Klassen et al., 2007). To our knowledge, no studies have included children with advanced 
cancer, because they are considered a vulnerable population and might not wish to participate in 
research. However, such research has great potential to further understand the experiences of 
individuals near the end of their life and inform interventions that prevent or reduce suffering 
(Hinds et al., 2004).  
 Thus, this study aimed to characterize benefit finding among children with advanced 
cancer and their parents and to identify individual and medical factors related to benefit finding. 
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This study fills a gap in psycho-oncology research by examining benefit finding in a population 
that is currently receiving treatment, investigating benefit finding in children, and exploring the 
association between parent and child benefit finding, all of which have received limited 
attention. We expected that child and parent benefit finding would be positively correlated, but 
that parents would have significantly greater benefit finding than children. We also expected that 
older age, female sex, longer time since diagnosis, and a diagnosis other than CNS tumor or 
leukemia would be related to higher levels of benefit finding in children with advanced cancer. 
Methods 
         Data for this paper were part of a larger study examining quality of life and decision 
making in children with advanced cancer and their parents. The larger study involved 
assessments and interviews with families at enrollment (T1), 6 months (T2), and 12 months (T3), 
as well as monthly, brief online surveys regarding the child’s symptoms and quality of life.   
Participants 
         Families were eligible for the study if the child had advanced cancer, were 5-25 years 
old, had at least one parent who spoke English, and lived within 140 miles of Nationwide 
Children’s Hospital. Advanced cancer was defined as any relapsed or refractory disease, 
physician estimated survival <60%, or referral to end-of-life care. Children with significant 
developmental disabilities were not eligible. Mothers, fathers, and the child with cancer were 
recruited for the study.  
Sample Charactersitics 
 Of 96 families approached to participate, 57 (59.3%) enrolled in the study, resulting in 45 
mothers, 24 fathers, and 36 children who were above age 8 and able to provide self-report. Data 
from one mother were dropped, because she did not complete the Benefit Finding Scale. Detailed 
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demographic characteristics are presented in Table 1. Of all 57 children in the study, the average 
age at T1 was 13.3 years (SD = 4.6), and most were male (N = 39; 68.4%), White (N = 48; 
84.2%), and/or non-Hispanic (N = 57, 100%). The most common diagnosis was brain tumors or 
other solid tumors (N = 35; 61.4%), with an average age at diagnosis of 10.5 years old (SD = 
5.3). Of the 36 children who provided self-report, the average age was 14.9 years old (SD = 3.4). 
The average age of mothers was 42 years old (SD = 6.01), and most were White (N = 38; 
86.4%), and/or non-Hispanic (N = 43; 97.3%). The average age of fathers was 43.8 years old (SD 
= 6.22), and most were White (N = 19; 79.2%), and/or non-Hispanic (N = 24, 100%).  
Procedures 
 Eligible families were identified through the palliative care or oncology teams, as well as 
review of inpatient records. The study coordinator contacted families in the clinic, hospital, or 
via phone to introduce the study and assess interest in participation. Following informed 
consent/assent, study staff scheduled a time to conduct an initial assessment with parents and 
children in the hospital or home. Participants above the age of 8 completed assessments if they 
were alert and able to provide self-report. If the child was below the age of 8, only parent report 
was obtained. Research assistants conducted each assessment with participants one on one, either 
virtually or in person depending on their enrollment during the COVID-19 pandemic, to ensure 
confidentiality and provide any assistance if needed. Families were compensated $40 for the 
initial home/hospital visit and $5 for monthly measurements. 
Measures 
Demographic Questionnaire. A demographic form was created by the research team to 
collect family background information such as age, date of birth, education level, race, 
household income, and religion.  
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The Benefit Finding Scale (BFS) (Antoni et al., 2001). The BFS was used to measure 
benefit finding in mothers and fathers with 17 items that ask about personal growth, relationship 
improvement, and purpose in life. Sample items include, “having a child with cancer has led me 
to be more accepting of things” or “having a child with cancer has contributed more to my 
overall emotional and spiritual growth.” The items were rated on a scale from 1 ‘not at all’ to 5 
‘extremely,’ resulting in an average item score. Evidence supports internal reliability and 
convergent and discriminant validity (Antoni et al., 2001). Construct validity was confirmed by 
two different studies (Pascoe and Edvardsson, 2015; Li et al., 2017). Internal consistency was 
acceptable for both mothers (=.93) and fathers in this sample (=.94). The BFS was 
administered to parents at T1, T2, and T3.  
The Benefit Finding Scale for Children (BFSC). This instrument assessed benefit finding 
in children using 10 items (Phipps et al., 2007). The BFSC provides statements like “having had 
my illness has helped me become a stronger person” or “having had my illness has helped me to 
be more patient.” Items are rated on a scale of 0 ‘not at all true for me’ to 5 ‘very true for me,’ 
resulting in an average item score. The BFSC has excellent reliability (Michel et al., 2010; 
Phipps et al., 2007) and was administered to children at T1, T2, and T3. Internal consistency was 
acceptable in this sample (=.85). 
Electronic Medical Records. Medical records were reviewed by research staff using a 
structured form to collect data about diagnosis type, time since diagnosis, and treatment type.  
Analysis Plan 
 Descriptive statistics were calculated for variables of interest. Average item scores were 
calculated only when at least 80% of items on the measure were completed by participants. 
Associations between parent and child benefit finding were examined using Pearson correlations 
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(α = .05, two-way), and paired t-tests (α = .05, two-way) were used to examine differences 
between informants within families (i.e., mother-child, father-child, mother-father). Associations 
between medical/demographic factors and benefit finding in both parents and children were also 
examined using Pearson correlations or t-tests (α = .05, two-way) as appropriate. Cohen’s d 
effect sizes were calculated for paired comparisions. To determine the relative contributions of 
significant demographic or medical factors to child and parent benefit finding, hierarchical 
regressions were planned. Using Gpower, the sample of 44 mothers provided power (.66 -.82) to 
detect medium effects for t-tests (d = .50) and correlations (r = .30) (Faul et al., 2007). The 
sample of 24 fathers and 36 children provided power (.83-.97) to detect large effects for t-tests (d 
= .80) and correlations (r = .50), respectively. 
Results 
Benefit Finding in Mothers, Fathers, and Children 
 The average benefit finding score for children was 3.82 (SD = 0.80), indicating moderate 
to high benefit finding on a 5-point scale. The average benefit finding score for mothers and 
fathers was 3.86 (SD = 0.81) and 3.17 (SD = 0.84), respectively, on a 5-point scale. Correlations 
can be found in Table 2. Child benefit finding scores were not significantly correlated with 
mother scores, r(27) = .22, p = .28, or father scores, r(15) = .21, p = .46. Mother and father 
benefit finding scores were also not significantly correlated, r(15) = .44, p = .10. Paired sample 
t-tests revealed there were no significant differences between mother benefit finding scores (M = 
3.58, SD = 0.87) and child benefit finding scores (M = 3.79, SD = 0.79), t(26) = 1.05, p = 0.30; d 
= 0.25. However, father benefit finding scores (M = 3.27, SD = 0.91) were significantly lower 
than child scores (M = 4.16, SD = 0.63), t(14) = -3.48, p = .004; d = 1.14. Mother (M = 3.55, SD 
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= 0.83) and father (M = 3.18, SD = 0.88) benefit finding scores did not differ, t(14) = 1.58, p = 
.14; d = 0.43. 
Associations between Benefit Finding, Demographic Characteristics, and Medical Factors 
 There were no significant differences in male (M = 3.78, SD = .69) and female (M = 3.91, 
SD = 1.02) benefit finding scores; t(34) = -0.418, p = .68; d = 0.13. Benefit finding scores did not 
differ between White (M = 3.83, SD = 0.82) and BIPOC children (M = 3.79, SD = 0.72); t(34) = 
0.096, p = .74; d = 0.04. Child scores were not significantly correlated with age at enrollment, 
r(36) = .26, p = .13, child age at diagnosis, r(36) = .19, p = .28, or time since diagnosis, r(36) = 
.001, p = .997. Due to small sample sizes, leukemia and brain tumor diagnoses were collapsed 
into one group and lymphoma and other solid tumors were collapsed into a second group. There 
were no significant differences in benefit finding for children diagnosed with leukemia/brain 
tumors (M = 3.95, SD = 0.69) or lymphoma/other solid tumors (M = 3.75, SD = 0.86); t(34) = 
0.863, p = .24; d = 0.26.  
 Parent age was unrelated to mother, r(44) = -.01, p = .93, and father benefit finding 
scores, r(24) = -.17, p = .44. Level of education was also not correlated with mother benefit 
finding scores, r(43) = .04, p = .78, or father benefit finding scores, r(24) = .03, p = .89. With 
regards to child medical factors, time since diagnosis and age of child at diagnosis were not 
significantly correlated with mother benefit finding, r(44) = -.17, p = .28 and r(44) = .11, p = 
.95, or father benefit finding r(24) = -.02, p = .93 and r(24) = -.17, p = .42, respectively. Benefit 
finding scores did not significantly differ between White mothers (M = 3.64, SD = .80) and 
BIPOC mothers (M = 3.91); t(42) = -0.794, p = .73; d = 0.33. Sample size restraints limited 
comparisons based on race of fathers. 
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 Due to the lack of significant associations between benefit finding and other demographic 
and medical factors, planned multi-variate models examining their relative contribution to 
benefit finding were not conducted. 
Discussion 
 Limited research has examined benefit finding in adults or children with advanced 
cancer. Using standardized measures to assess benefit finding in both parents and children, this 
study is one of the first to explore benefit finding among multiple family members, as well as 
potentially related demographic and medical factors, in the context of the child’s advanced 
disease. The results of this study show that despite having an unlikely prospect of cure, both the 
children with cancer and their parents found moderate to high levels of benefit finding from the 
cancer experience. In general, family members were able to report benefits independent of one 
another, and there were few demographic or medical factors associated with variability in benefit 
finding.  
 Children with advanced cancer in the current study had moderate to high levels of 
bebenfit finding, which was higher than in other populations of children with cancer (Phipps et 
al., 2007; Michel et al., 2009). This could be due to the curvilinear relationship between stress 
and benefit finding, which proposes that too little stress will not result in benefit finding, while 
benefit finding is unable to occur if stress is too high (Lechner et al., 2003; Cordova et al., 2001; 
Helgeson et al. 2006). Given that most children in the sample were not imminently at the end of 
life, it is possible that they had sufficient, but not overwhelming, stress to account for this effect.   
Parent benefit finding scores were also moderate to high and comparable to scores in 
adults with cancer (Lechner et al., 2003; Applebaum et al., 2020; Llewellyn et al. 2013). When 
compared to child benefit finding scores, father benefit finding scores were significantly lower, 
BENEFIT FINDING IN PEDIATRIC CANCER PATIENTS 
 
15 
but mother scores were not significanly different from those of children or fathers. Fathers may 
not process the trauma of their child’s cancer diagnoses in a way that results in the same levels of 
benefit finding as children who have cancer; however, future work is still needed to better 
understand father-child dyads in pediatric oncology (Stanton et al., 2006). Although fathers had 
significantly lower benefit finding scores compared to their children, it should be noted that they 
did still find moderate levels of benefit finding. Our data also suggest that child and parent 
benefit finding may be relatively independent of one another. Benefit finding between father and 
child, mother and child, and mother and father were not significantly correlated, as was also 
found in a study of survivors of childhood cancer (Michel et al., 2009). However, the moderately 
sized correlations between mothers and fathers in the current study suggest the possibility of 
associations and need for additional research. 
 Unlike many other studies investigating benefit finding in individuals with cancer, we did 
not find any significant associations with demographic variables. Most of the literature suggests 
a curvilinear relationship between age and benefit finding, with very young children and older 
adults finding less benefit than middle aged teenagers and adults (Helgeson et al., 2006; Husson 
et el., 2017; Linley & Joseph, 2004). Our sample did not exhibit any significant correlations 
between age at enrollment and benefit finding in both parents and children, as has been 
previously found in the child literature (Phipps et al., 2007). However, correlations between child 
age and benefit finding were weak to moderate sized (r = .26) and in the expected direction. 
Child age at diagnosis was also not significantly correlated with benefit finding, contrasting other 
studies that have found that children who are younger at diagnosis find less benefit than children 
who are older (Michel et al., 2009; Phipps et al., 2007; Barakat et al., 2005). This could be a 
result of only children ages 8 and older completing self-reports of benefit finding.  
BENEFIT FINDING IN PEDIATRIC CANCER PATIENTS 
 
16 
Time since diagnosis also did not exhibit any significant associations with benefit 
finding, contrasting other studies that found a negative association with time since diagnosis 
(Phipps et al., 2007; Michel et al. 2009). This is likely because both of these studies recruited 
cancer survivors who were many years past their diagnosis. The literature suggests that once a 
person is no longer receiving treatment for a long period of time, benefit finding scores decrease 
(Phipps et al., 2007). However, because our sample of children with advanced cancer were still 
undergoing treatment during the study, they may have been unlikely to show the same decline in 
benefit finding (Phipps et al., 2007). 
 Other demographic characteristics such as sex, family income, race, parent education, 
and cancer type did not reveal any significant associations with mother, father, or child benefit 
finding. With regards to sex differences, male and female children did not have significantly 
different benefit finding scores, which has also been found in previous literature (Phipps et al., 
2007; Michel et al., 2010; Lechner et al., 2003). There were also no significant differences 
between mothers and fathers, contrasting the literature that supports sex differences in benefit 
finding (Helgeson et al., 2006; Barakat et al., 2005; Tomich & Helgeson, 2004; Husson et al., 
2017). However, our study had a small number of parent dyads, which restricted our ability to 
compare scores between mothers and fathers.  
 Previous literature is mixed regarding associations between income and benefit finding 
with some studies finding no associations and others finding a negative association (Lechner et 
al., 2003; Linley & Joseph, 2004; Tomic & Helgeson, 2004). Although our study did not find 
any significant correlations with family income, moderately sized correlations among fathers (r = 
-.36) suggest futher exploration is needed in larger samples. In addition, parent education was 
also not a significant predictor of benefit finding, but small correlations with mothers’ education 
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level (r = -.26) are consistent with previous work. Specifically, research suggests that individuals 
with lower education and income are more experienced at finding positive aspects out of 
negative life events (Phipps et al., 2007). Because life threatening cancer is such an prominent 
stressor however, this stress could have possibly overshadowed any effects of other demographic 
variables on benefit finding.  
Child benefit finding was not significantly different when compared between diagnostic 
groups, contrasting research showing that children with leukemia find more benefit compared to 
other diagnosis groups (Michel et al., 2009). However, previous work examined children who 
were years past their cancer diagnosis. Leukemia often requires much longer treatment than solid 
tumors and CNS tumors, suggesting that children who had leukemia found more benefits from 
their cancer experience because it affected their life differently than other cancers. In this study, 
all participants were still receiving some form of treatment, so differences in benefit finding 
scores across diagnostic groups may not have been identified. Of note, we were limited in our 
comparison of treatments groups, as only two children with CNS tumors were able to complete 
the benefit finding measure. The lack of any significant associations suggests that benefit finding 
may occur in children and parents regardless of these demographic or medical factors. 
 There are a variety of limitations that should be considered when reviewing the 
conclusions of this study. Restrictions due to the COVID-19 pandemic disrupted recruitment at 
the hospital and clinics, as well as in-person data collection for these immune compromised 
patients. Despite attempts to shift to remote methods, our sample size was smaller than 
anticipated, and participation of each family member varied from family to family. Twenty-four 
fathers out of 57 families participated in the study, which restricted the ability to examine 
associations with child and mother benefit finding, as well as differences based on various 
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background factors for fathers. The overall sample size also led to a smaller number of children 
with brain tumors who were able to complete measures. Brian tumors are more likely to be 
diagnosed in young children (under age 5), which limited enrollment and the ability to compare 
benefit finding across diagnosis groups. The sample was also predominantly White and non-
Hispanic, which limits generalizability to other racial groups. The sample was recruited from 
only one site, and further studies should include multiple institutions to increase diversity and 
generalizability to other regions. Given the cross-sectional design of this work, studies should 
also investigate benefit finding at multiple points over a longer period of time to understand how 
benefit finding develops and evolves for both children and parents. Lastly, future research should 
investigate how benefit finding could serve as a protective factor against distress and other 
negative outcomes.  
 Despite these limitations, this study is one of the first to examine benefit finding among 
children with advanced cancer and explore associations between child and parent benefit finding. 
Our results show that children with advanced disease can still find benefits from their cancer 
experience, and demographic and medical factors do not necessarily determine who is more or 
less likely to find benefits. With this information, clinicians and parents may be reassured that 
many children with advanced cancer may exhibit resilience in spite of significant adversity. Such 
adversity may bring into sharper focus the importance of close relationships, positive 
experiences, and finding a silver lining in midst of unimaginable challenges. If family members 
are receptive, clinicians should continue to encourage finding meaning from a cancer diagnosis, 
which has been shown to be valuable in both children, parents, and adults at the end of life 
(Schaefer et al., 2020; Breitbart et al., 2004). Additionally, clinicians can interpret from this data 
that parent and child benefit finding may be independent of one another and can be fostered 
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regardless of how other members of the family experience benefit finding. Thus, many children 
with advanced cancer and their parents can still navigate the positive and meaningful aspects of 
their lives despite having a life threatening illness.  
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TABLE 1: Demographic Characteristics of Mothers, Fathers, and all Children   
  Mothers  
(n = 44) 
Fathers  
(n = 24) 
Children   
(n = 57)  
 
  M (SD), range    
Age at T1 (yrs.)  42.00 (6.01), 26.6-56.6  43.80 (6.22), 30.5-54  13.3 (4.6), 5.4-23.2   
Age at diagnosis (yrs.)     10.5 (5.3), 1.0-20.4  
Time since diagnosis (yrs.)   3.94 (1.31), 0.89-5.98   
n (%)   
Level of completed 
education  
       
    High school or grade 
school  
10 (23.3%)  7 (29.2%)     
    College, technical/trade 
school 
21 (48.8%)  12 (50%)     
Graduate/professional 
degree  
12 (27.9%)  5 (20.8%)     
Income         
    Under-$25,000 per yr. 9 (20.5%)  5 (20.8%)     
    $25,001-$50,000 per yr.  7 (15.9%)  2 (8.3%)     
    $50,000-$75,000 per yr.  6 (13.6%)  5 (20.8%)     
    $75,001-$100,000 per yr.  6 (13.6%)  5 (20.8%)     
    $100,001-$150,000 per yr. 5 (11.3%)  3 (12.5%)     
    $150,001 or more  8 (18.1%)  3 (12.5%)     
    unknown  3 (6.8%)  1 (4.2%)     
Race         
    White  38 (86.4%)  19 (79.2%)  48 (84.2%)   
    African-American  0 (0%)  1 (4.2%)  1 (1.8%)   
Asian  3 (6.8%)  3 (12.5%)  4 (7%)   
Other   3 (6.8%)  1 (4.2%)  4 (7%)   
Native Hawaiian/Pacific 
Islander   
0 (0%)  0 (0%)  0 (0%)   
American Indian/Native 
Alaskan  
0 (0%)  0 (0%)  0 (0%)   
Ethnicity          
Non-Hispanic/Latinx 43 (97.7%)  24 (100%)  57 (100%)   
Hispanic/Latinx 0 (0%)  0 (0%)  0 (0%)   
Unknown  1 (2.3%)  0 (0%)  0 (0%)   
Sex         
Male  0 (0%)  24 (100%)  39 (68.4%)   
Female  43 (100%)  0 (0%)  18 (31.6%)   
Diagnosis type         
    Leukemia      17 (29.8%)   
    Lymphoma      5 (8.8%)   
    Brain tumor      10 (17.5%)   
    Other Solid Tumor      25 (43.9%)   
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Table 2: Correlations between Benefit Finding and Demographic Variables 
  Child BFSC Mother BFS  Father BFS  
Child BFS   - -  -  
Mother BFS  .22   - -  
Father BFS  .21  .44   - 
Child Age at T1  .26  -.09  -.18  
Mother Age at T1  .37  -.01  -.29  
Father Age at T1  -.12  -.06  -.17  
Child Age at Diagnosis  .19  .01  -.17  
Child Time Since DX  .00  -.17  -.02  
Mother Education -.26 .04 .14 
Father Education -.18 .10 .03 
Mother Income -.13 -.07 -.06 
Father Income -.36 -.11 .01 
Note. N ranges from 15-44. All correlations non-significant. 
 
  




Antoni, M. H., Lehman, J. M., Kilbourn, K. M., Boyers, A. E., Culver, J. L., Alferi, S. M., 
Yount, S. E., McGregor, B. A., Arena, P. L., Harris, S. D., Price, A. A., & Carver, C. S. 
(2001). Cognitive-behavioral stress management intervention decreases the prevalence of 
depression and enhances benefit finding among women under treatment for early-stage 
breast cancer. Health Psychology, 20(1), 20–32. https://doi.org/10.1037/0278-
6133.20.1.20 
Applebaum, A. J., Marziliano, A., Schofield, E., Breitbart, W., & Rosenfeld, B. (2020). 
Measuring positive psychosocial sequelae in patients with advanced 
cancer. Psychological Trauma: Theory, Research, Practice and Policy, 2020 Sep 03. 
https://doi.org/10.1037/tra0000944 
Barakat, L. P., Alderfer, M. A., & Kazak, A. E. (2005). Posttraumatic Growth in Adolescent 
Survivors of Cancer and Their Mothers and Fathers. Journal of Pediatric Psychology, 
31(4), 413–419. doi: 10.1093/jpepsy/jsj058 
Bennett, D. S. (1994). Depression among children with chronic medical problems: A meta-
analysis. Journal of Pediatric Psychology, 19, 149–169. 
Berger, R., & Weiss, T. (2009). The posttraumatic growth model: An expansion to the family 
system. Traumatology, 15(1), 63-74. 
Breitbart, W., Gibson, C., Poppito, S. R., & Berg, A. (2004). Psychotherapeutic interventions at 
the end of life: a focus on meaning and spirituality. Canadian Journal of 
Psychiatry, 49(6). 
BENEFIT FINDING IN PEDIATRIC CANCER PATIENTS 
 
23 
Carver, C. S., & Antoni, M. H. (2004). Finding Benefit in Breast Cancer During the Year After 
Diagnosis Predicts Better Adjustment 5 to 8 Years After Diagnosis. Health Psychology, 
23(6), 595-598. http://dx.doi.org.proxy.lib.ohio-state.edu/10.1037/0278-6133.23.6.595 
Clarke, N. E., McCarthy, M. C., Downie, P., Ashley, D. M., & Anderson, V. A. (2009). Gender 
differences in the psychosocial experience of parents of children with cancer: a review of 
the literature. Psycho-Oncology, 18(9), 907–15. https://doi.org/10.1002/pon.1515 
Compas, B. E., Desjardins, L., Vannatta, K., Young-Saleme, T., Rodriguez, E. M., Dunn, M., . . . 
Gerhardt, C. A. (2014). Children and adolescents coping with cancer: Self- and parent 
reports of coping and anxiety/depression. Health Psychology, 33(8), 853-861. 
doi:10.1037/hea0000083 
Compas, B. E., Jaser, S. S., Reeslund, K., Patel, N., & Yarboi, J. (2017). Neurocognitive deficits 
in children with chronic health conditions. American Psychologist, 72(4), 326–
338. https://doi.org/10.1037/amp0000042 
Cordova M, Cunningham L, Carlson C, Andrykowski M. (2001). Posttraumatic growth 
following breast cancer a controlled comparison study, Health Psychology, vol. 20 (pg. 
176-185) 
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007). G*Power 3: A flexible statistical 
power analysis program for the social, behavioral, and biomedical sciences. Behavior 
Research Methods, 39(2), 175–191. 
Gable, S. L., & Haidt, J. (2005). What (and why) is positive psychology? Review of General 
Psychology, 9(2), 103–110. https://doi-org.proxy.lib.ohio-state.edu/10.1037/1089-
2680.9.2.103 
BENEFIT FINDING IN PEDIATRIC CANCER PATIENTS 
 
24 
Gardner, M. H., Mrug, S., Schwebel, D. C., Phipps, S., Whelan, K., & Madan‐Swain, A. (2017) 
Demographic, medical, and psychosocial predictors of benefit finding among caregivers 
of childhood cancer survivors. Psycho‐Oncology. 26: 125– 132. doi: 10.1002/pon.4014. 
Helgeson, V. S., Reynolds, K. A., & Tomich, P. L. (2006). A meta-analytic review of benefit 
finding and growth. Journal of Consulting and Clinical Psychology, 74(5), 797–816. doi: 
10.1037/0022-006x.74.5.797 
Hewitt, M., Weiner, S.L. & Simone, J.V.for the National Cancer Policy Board. (2003). 
Childhood cancer survivorship: Improving care and quality of life. Washington, DC: 
National Academies Press. 
Hinds, P. S., Pritchard, M., & Harper, J. (2004). End-of-Life Research as a Priority for Pediatric 
Oncology. Journal of Pediatric Oncology Nursing, 21(3), 175–179. 
https://doi.org/10.1177/1043454204264386 
Husson, O., Zebrack, B., Block, R., Embry, L., Aguilar, C., Hayes-Lattin, B., & Cole, S. (2017). 
Posttraumatic growth and well-being among adolescents and young adults (AYAs) with 
cancer: a longitudinal study. Supportive Care in Cancer, 25(9), 2881–2890. doi: 
10.1007/s00520-017-3707-7 
Jantien Vrijmoet-Wiersma, C. M., van Klink, J. M. M., Kolk, A. M., Koopman, H. M., Ball, L. 
M., & Maarten Egeler, R. (2008). Assessment of parental psychological stress in 
pediatric cancer: a review. Journal of Pediatric Psychology, 33(7), 694–706. 
Kersun, L.S., Rourke, M.T., Mickley, M.& Kazak, A.E. (2009). Screening for depression and 
anxiety in adolescent cancer patients. Journal of Pediatric Hematology Oncology, 31, 
836–839. 
BENEFIT FINDING IN PEDIATRIC CANCER PATIENTS 
 
25 
Klassen, A., Raina, P., Reineking, S., Dix, D., Pritchard, S., & O’Donnell, M. (2007). 
Developing a literature base to understand the caregiving experience of parents of 
children with cancer: a systematic review of factors related to parental health and well-
being. SUPPORTIVE CARE IN CANCER, 15(7), 807–818. https://doi-org.proxy.lib.ohio-
state.edu/10.1007/s00520-007-0243-x 
Krull, K. R., Gioia, G., Ness, K. K., Ellenberg, L., Recklitis, C., Leisenring, W., … Zeltzer, L. 
(2008). Reliability and validity of the childhood cancer survivor study neurocognitive 
questionnaire. Cancer, 113(8), 2188–2197. https://doi.org/10.1002/cncr.23809 
Lechner, S. C., Zakowski, S. G., Antoni, M. H., Greenhawt, M., Block, K., & Block, P. (2003). 
Do sociodemographic and disease-related variables influence benefit-finding in cancer 
patients? Psycho-Oncology, 12(5), 491–499. doi: 10.1002/pon.671 
Li, Q., Lin, Y., Xu, Y., Zhou, H., & Yang, L. (2017). Construct validity of the 17-item benefit 
finding scale in chinese cancer patients and their family caregivers: a cross-sectional 
study. Supportive Care in Cancer: Official Journal of the Multinational Association of 
Supportive Care in Cancer, 25(8), 2387–2397. doi.org/10.1007/s00520-017-3644-5 
Long, K. A., & Marsland, A. L. (2011). Family adjustment to childhood cancer: a systematic 
review. Clinical Child and Family Psychology Review, 14(1), 57–88. 
https://doi.org/10.1007/s10567-010-0082-z 
Marusak, H. A., Iadipaolo, A. S., Harper, F. W., Elrahal, F., Taub, J. W., Goldberg, E., & 
Rabinak, C. A. (2017). Neurodevelopmental consequences of pediatric cancer and its 
treatment: applying an early adversity framework to understanding cognitive, behavioral, 
and emotional outcomes. Neuropsychology Review, 28(2), 123–175. doi: 
10.1007/s11065-017-9365-1 
BENEFIT FINDING IN PEDIATRIC CANCER PATIENTS 
 
26 
Michel, G., Taylor, N., Absolom, K., & Eiser, C. (2010). Benefit finding in survivors of 
childhood cancer and their parents: Further empirical support for the benefit finding scale 
for children. Child: Care, Health and Development, 36(1), 123-9. doi:10.1111/j.1365-
2214.2009.01034.x 
National Cancer Institute. (n.d.). NCI Dictionary of Cancer Terms. Retrieved April 10, 2020, 
from https://www.cancer.gov/publications/dictionaries/cancer-terms 
National Cancer Institute. (2015, November 13). Pediatric Supportive Care (PDQ®)–Patient 
Version. Retrieved July 24, 2020, from https://www.cancer.gov/types/childhood-
cancers/pediatric-care-pdq 
Okado, Y., Long, A. M., & Phipps, S. (2014). Association Between Parent and Child Distress 
and the Moderating Effects of Life Events in Families With and Without a History of 
Pediatric Cancer. Journal of Pediatric Psychology, 39(9), 1049–1060. doi: 
10.1093/jpepsy/jsu058   
Pai, A. L. H., Greenley, R. N., Lewandowski, A., Drotar, D., Youngstrom, E., & Peterson, C. C. 
(2007). A meta-analytic review of the influence of pediatric cancer on parent and family 
functioning. Journal of Family Psychology, 21(3), 407–415. 
Pakenham, K., & Cox, S. (2009). The dimensional structure of benefit finding in multiple 
sclerosis and relations with positive and negative adjustment: A longitudinal study. 
Psychology & Health, 24(4), 373-93. doi:10.1080/08870440701832592 
Pascoe, L., & Edvardsson, D. (2015). Psychometric properties and performance of the 17-item 
benefit finding scale (bfs) in an outpatient population of men with prostate cancer. 
European Journal of Oncology Nursing, 19(2), 169–173. 
https://doi.org/10.1016/j.ejon.2014.09.004 
BENEFIT FINDING IN PEDIATRIC CANCER PATIENTS 
 
27 
Phipps, S., Long, A. M., & Ogden, J. (2007). Benefit Finding Scale for Children: Preliminary 
Findings from a Childhood Cancer Population. Journal of Pediatric Psychology, 32(10), 
1264–1271. doi: 10.1093/jpepsy/jsl052 
Pinquart, M., & Shen, Y. (2011). Depressive symptoms in children and adolescents with chronic 
physical illness: an updated meta-analysis. Journal of Pediatric Psychology, 36(4), 375–
384. 
Portteus, A., Ahmad, N., Tobey, D. & Leavey, P. (2006). Prevalence and use of antidepressant 
medication in pediatric cancer patients. Journal of Child and Adolescent 
Psychopharmacology, 16, 467–473. 
Rodriguez, E. M., Dunn, M. J., Zuckerman, T., Vannatta, K., Gerhardt, C. A., & Compas, B. E. 
(2012). Cancer-related sources of stress for children with cancer and their parents. 
Journal of Pediatric Psychology, 37(2), 185–97. https://doi.org/10.1093/jpepsy/jsr054 
Rosenberg, A. R., Baker, K. S., Syrjala, K., & Wolfe, J. (2012). Systematic review of 
psychosocial morbidities among bereaved parents of children with cancer. Pediatric 
Blood & Cancer, 58(4), 503–12. https://doi.org/10.1002/pbc.23386 
Schaefer, M. R., Kenney, A. E., Himelhoch, A. C., Howard, S. K. M., Humphrey, L., Olshefski, 
R., … Gerhardt, C. A. (2020). A quest for meaning: a qualitative exploration among 
children with advanced cancer and their parents. Psycho-Oncology, 2020 Nov 23. 
https://doi.org/10.1002/pon.5601 
Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics, 2019. Ca: A Cancer Journal 
for Clinicians, 69(1), 7–34. https://doi.org/10.3322/caac.21551 
BENEFIT FINDING IN PEDIATRIC CANCER PATIENTS 
 
28 
Stanton, A. L., Bower, J. E., & Low, C. A. (2006). Posttraumatic growth after cancer. In L. G. 
Calhoun & R. G. Tedeschi (Eds.), Handbook of posttraumatic growth: Research and 
practice (pp. 138–175). Mahwah, NJ: Erlbaum. 
Stuber, M. & Strom, E. (2012). Pediatric psycho-oncology. In L. Glassi & M. Riba (Eds), 
Clinical Psycho-Oncology: An International Perspective (pp. 139–153). Oxford: Wiley 
Blackwell. 
Tedeschi, R., & Calhoun, L. (1996). The posttraumatic growth inventory: Measuring the positive 
legacy of trauma. Journal of Traumatic Stress, 9, 455–472. 
Tedeschi, R. G. & Calhoun, L. G. (2004). TARGET ARTICLE: "Posttraumatic Growth: 
Conceptual Foundations and Empirical Evidence", Psychological Inquiry, 15:1, 1-18, 
DOI: 10.1207/s15327965pli1501_01 
Tedeschi, R., Park, C., & Calhoun, L. (1998). Posttraumatic growth: Positive changes in the 
aftermath of crisis (The lea series in personality and clinical psychology). Mahwah, N.J.: 
Erlbaum. 
Tomich, P. L. & Helgeson, V. S. (2004) Is finding something good in the bad always good? 
Benefit finding among women with breast cancer. Health Psychology, 23, 16–23. 
Wulff-Burchfield, E., Dietrich, M. S., Ridner, S., & Murphy, B. A. (2019). Late systemic 
symptoms in head and neck cancer survivors. Supportive Care in Cancer, 27(8), 2893–
2902. https://doi.org/10.1007/s00520-018-4577-3 
Zeltzer, L. K., Recklitis, C., Buchbinder, D., Zebrack, B., Casillas, J., Tsao, J. C., Lu, Q., & 
Krull, K. (2009). Psychological status in childhood cancer survivors: a report from the 
Childhood Cancer Survivor Study. Journal of clinical oncology: official journal of the 
BENEFIT FINDING IN PEDIATRIC CANCER PATIENTS 
 
29 
American Society of Clinical Oncology, 27(14), 2396–2404. 
https://doi.org/10.1200/JCO.2008.21.1433  
